IndyGeneUS AI and the Blockchain-Secured Genomic Data Marketplace

Published on :

IndyGeneUS AI and the Blockchain-Secured Genomic Data Marketplace IndyGeneUS AI, which is harnessing the power of data mining and artificial intelligence to expedite the development and manufacturing of targeted therapeutics, [….]

Are Life Sciences Companies Going To Be Late To The Blockchain/Digital Assets Party?

Published on :

As of this week, there’s been heavy reporting that the Biden Administration has prepared new guidance on digital assets that could be released at any moment. Most of these reports suggest that the guidance will be centered around directing government agencies to study the potential benefits of Central Bank Digital Currencies (CBDCs), or tokenized versions of the US Dollar ($USD). These CBDCs have the capability to be minted on-demand and are programmable based on monetary policy set by the Federal Reserve and other entities. There’s other uses when paired with other digital assets that have the potential to improve and modernize the global financial system. 

IndyGeneUS AI Pledges Whole Genome Sequencing of 2M Samples Through Partnership with Aurum Institute in South Africa

IndyGeneUS Logo
Published on :

IndyGeneUS AI, a leader in whole genome sequencing and machine learning-powered bioinformatics analysis secured a partnership with Global Health Innovations Ltd. and The Aurum Institute in Johannesburg, South Africa. Aurum is currently building a bio-repository to increase capacity to accommodate up to 2-million genetic samples.

LucasPye and IndyGeneUS AI Forge Partnership To Address Drug Development and the African Diaspora

Published on :

Over the years, minority input in the clinical development of life-saving drugs has been lacking, particularly when it comes to clinical trial participation. That has led to disparities in the efficacy of medications when taken by minority

Philadelphia-based LucasPye Bio announces first contract manufacturing partnership

Published on :

LucasPye Bio, a Philadelphia biologics contract development and manufacturing organization, has formed a partnership with Africa-based genomics company IndyGeneUS AI aimed at advancing targeted therapeutics focused on health disparities.